Keyphrases
Inhibitor Response
100%
Rat Model
100%
Bleeding
100%
Joint Bleeding
100%
Hemophilia
42%
Danger Signals
28%
Knee
28%
Factor VIII (FVIII)
28%
Recombinant Human
28%
Neutralizing Antibodies
28%
Knee Joint
28%
Enzyme-linked Immunosorbent Assay (ELISA)
14%
Joint Treatment
14%
Binding Antibodies
14%
Immune Response
14%
Potential Danger
14%
Antibody Response
14%
Recombinant Factor VIII
14%
Adjuvant Effect
14%
Bethesda
14%
Sham Procedure
14%
Replacement Therapy
14%
Serious Complications
14%
One-group
14%
Bleeding Episodes
14%
Response to Treatment
14%
Coagulation Factor VIII
14%
Sham
14%
Pharmacology, Toxicology and Pharmaceutical Science
Haemophilia A
100%
Rat Model
100%
Blood Clotting Factor 8
100%
Ciclonicate
100%
Neutralizing Antibody
22%
Replacement Therapy
22%
Enzyme-Linked Immunosorbent Assay
11%
Bleeding
11%
Blood Clotting Factor
11%
Medicine and Dentistry
Haemophilia A
100%
Ciclonicate
100%
Blood Clotting Factor 8
100%
Substitution Therapy
22%
Neutralizing Antibody
22%
Knee Joint
22%
Antibody Response
11%
Immune Response
11%
Adjuvant Therapy
11%
Coagulation Factor VIII
11%
Sham Procedure
11%
Enzyme Linked Immunosorbent Assay
11%
Bleeding
11%
Nursing and Health Professions
Ciclonicate
100%
Haemophilia A
100%
Neutralizing Antibody
22%
Substitution Therapy
22%
Bleeding
11%
Sham Procedure
11%
Blood Clotting Factor
11%
Adjuvant Therapy
11%
Enzyme Linked Immunosorbent Assay
11%